Logo image of MLI

MUELLER INDUSTRIES INC (MLI) Stock Fundamental Analysis

NYSE:MLI - New York Stock Exchange, Inc. - US6247561029 - Common Stock - Currency: USD

80.27  +2.07 (+2.65%)

Fundamental Rating

7

Taking everything into account, MLI scores 7 out of 10 in our fundamental rating. MLI was compared to 127 industry peers in the Machinery industry. MLI gets an excellent profitability rating and is at the same time showing great financial health properties. MLI is not valued too expensively and it also shows a decent growth rate. This makes MLI very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year MLI was profitable.
MLI had a positive operating cash flow in the past year.
In the past 5 years MLI has always been profitable.
In the past 5 years MLI always reported a positive cash flow from operatings.
MLI Yearly Net Income VS EBIT VS OCF VS FCFMLI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

MLI has a Return On Assets of 18.38%. This is amongst the best in the industry. MLI outperforms 96.06% of its industry peers.
MLI has a Return On Equity of 21.81%. This is amongst the best in the industry. MLI outperforms 84.25% of its industry peers.
Looking at the Return On Invested Capital, with a value of 19.67%, MLI belongs to the top of the industry, outperforming 95.28% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MLI is significantly above the industry average of 10.84%.
The last Return On Invested Capital (19.67%) for MLI is well below the 3 year average (25.47%), which needs to be investigated, but indicates that MLI had better years and this may not be a problem.
Industry RankSector Rank
ROA 18.38%
ROE 21.81%
ROIC 19.67%
ROA(3y)23.2%
ROA(5y)21.16%
ROE(3y)28.12%
ROE(5y)28.13%
ROIC(3y)25.47%
ROIC(5y)24.78%
MLI Yearly ROA, ROE, ROICMLI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

MLI has a better Profit Margin (16.05%) than 92.13% of its industry peers.
In the last couple of years the Profit Margin of MLI has grown nicely.
MLI's Operating Margin of 20.28% is amongst the best of the industry. MLI outperforms 88.98% of its industry peers.
In the last couple of years the Operating Margin of MLI has grown nicely.
The Gross Margin of MLI (27.71%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MLI has grown nicely.
Industry RankSector Rank
OM 20.28%
PM (TTM) 16.05%
GM 27.71%
OM growth 3Y8.37%
OM growth 5Y21.34%
PM growth 3Y8.89%
PM growth 5Y31.03%
GM growth 3Y7.95%
GM growth 5Y11.43%
MLI Yearly Profit, Operating, Gross MarginsMLI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MLI is creating value.
Compared to 1 year ago, MLI has less shares outstanding
Compared to 5 years ago, MLI has about the same amount of shares outstanding.
MLI has a better debt/assets ratio than last year.
MLI Yearly Shares OutstandingMLI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MLI Yearly Total Debt VS Total AssetsMLI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MLI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.78
WACC11.07%
MLI Yearly LT Debt VS Equity VS FCFMLI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

MLI has a Current Ratio of 5.06. This indicates that MLI is financially healthy and has no problem in meeting its short term obligations.
MLI's Current ratio of 5.06 is amongst the best of the industry. MLI outperforms 90.55% of its industry peers.
A Quick Ratio of 3.89 indicates that MLI has no problem at all paying its short term obligations.
MLI has a better Quick ratio (3.89) than 92.13% of its industry peers.
Industry RankSector Rank
Current Ratio 5.06
Quick Ratio 3.89
MLI Yearly Current Assets VS Current LiabilitesMLI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.75% over the past year.
Measured over the past years, MLI shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.60% on average per year.
The Revenue has grown by 10.19% in the past year. This is quite good.
Measured over the past years, MLI shows a quite strong growth in Revenue. The Revenue has been growing by 9.17% on average per year.
EPS 1Y (TTM)14.75%
EPS 3Y8.81%
EPS 5Y42.6%
EPS Q2Q%21%
Revenue 1Y (TTM)10.19%
Revenue growth 3Y0%
Revenue growth 5Y9.17%
Sales Q2Q%26.1%

3.2 Future

The Earnings Per Share is expected to grow by 9.90% on average over the next years. This is quite good.
MLI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.98% yearly.
EPS Next Y7.47%
EPS Next 2Y9.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.13%
Revenue Next 2Y9.98%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
MLI Yearly Revenue VS EstimatesMLI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
MLI Yearly EPS VS EstimatesMLI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.12, the valuation of MLI can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of MLI indicates a somewhat cheap valuation: MLI is cheaper than 77.17% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of MLI to the average of the S&P500 Index (29.41), we can say MLI is valued slightly cheaper.
With a Price/Forward Earnings ratio of 14.07, MLI is valued correctly.
MLI's Price/Forward Earnings ratio is rather cheap when compared to the industry. MLI is cheaper than 81.10% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.12, MLI is valued a bit cheaper.
Industry RankSector Rank
PE 15.12
Fwd PE 14.07
MLI Price Earnings VS Forward Price EarningsMLI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

74.80% of the companies in the same industry are more expensive than MLI, based on the Enterprise Value to EBITDA ratio.
83.46% of the companies in the same industry are more expensive than MLI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.14
EV/EBITDA 9.56
MLI Per share dataMLI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MLI does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MLI may justify a higher PE ratio.
PEG (NY)2.02
PEG (5Y)0.35
EPS Next 2Y9.9%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

MLI has a Yearly Dividend Yield of 1.27%.
Compared to an average industry Dividend Yield of 1.74, MLI pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.30, MLI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.27%

5.2 History

The dividend of MLI is nicely growing with an annual growth rate of 31.86%!
MLI has been paying a dividend for at least 10 years, so it has a reliable track record.
MLI has decreased its dividend recently.
Dividend Growth(5Y)31.86%
Div Incr Years1
Div Non Decr Years1
MLI Yearly Dividends per shareMLI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

14.73% of the earnings are spent on dividend by MLI. This is a low number and sustainable payout ratio.
The dividend of MLI is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP14.73%
EPS Next 2Y9.9%
EPS Next 3YN/A
MLI Yearly Income VS Free CF VS DividendMLI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
MLI Dividend Payout.MLI Dividend Payout, showing the Payout Ratio.MLI Dividend Payout.PayoutRetained Earnings

MUELLER INDUSTRIES INC

NYSE:MLI (3/5/2025, 2:43:10 PM)

80.27

+2.07 (+2.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-04 2025-02-04/bmo
Earnings (Next)04-21 2025-04-21/bmo
Inst Owners92.72%
Inst Owner Change-1.01%
Ins Owners2.48%
Ins Owner Change0.2%
Market Cap9.13B
Analysts84
Price Target107.1 (33.42%)
Short Float %3.23%
Short Ratio4.15
Dividend
Industry RankSector Rank
Dividend Yield 1.27%
Yearly Dividend0.78
Dividend Growth(5Y)31.86%
DP14.73%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-14 2025-03-14 (0.25)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.99%
Min EPS beat(2)6.97%
Max EPS beat(2)11.01%
EPS beat(4)4
Avg EPS beat(4)10.07%
Min EPS beat(4)6.97%
Max EPS beat(4)14.1%
EPS beat(8)7
Avg EPS beat(8)32.44%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)3.97%
Min Revenue beat(2)2.4%
Max Revenue beat(2)5.55%
Revenue beat(4)3
Avg Revenue beat(4)3.16%
Min Revenue beat(4)-3.75%
Max Revenue beat(4)8.44%
Revenue beat(8)6
Avg Revenue beat(8)3.78%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)110%
EPS NQ rev (1m)-1.5%
EPS NQ rev (3m)0%
EPS NY rev (1m)3.67%
EPS NY rev (3m)6.6%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 15.12
Fwd PE 14.07
P/S 2.42
P/FCF 16.14
P/OCF 14.14
P/B 3.29
P/tB 3.29
EV/EBITDA 9.56
EPS(TTM)5.31
EY6.62%
EPS(NY)5.71
Fwd EY7.11%
FCF(TTM)4.97
FCFY6.2%
OCF(TTM)5.68
OCFY7.07%
SpS33.13
BVpS24.38
TBVpS24.38
PEG (NY)2.02
PEG (5Y)0.35
Profitability
Industry RankSector Rank
ROA 18.38%
ROE 21.81%
ROCE 26.42%
ROIC 19.67%
ROICexc 31.03%
ROICexgc 31.03%
OM 20.28%
PM (TTM) 16.05%
GM 27.71%
FCFM 15.01%
ROA(3y)23.2%
ROA(5y)21.16%
ROE(3y)28.12%
ROE(5y)28.13%
ROIC(3y)25.47%
ROIC(5y)24.78%
ROICexc(3y)43.75%
ROICexc(5y)36.53%
ROICexgc(3y)50.69%
ROICexgc(5y)43.25%
ROCE(3y)34.22%
ROCE(5y)33.28%
ROICexcg growth 3Y-10.72%
ROICexcg growth 5Y12.91%
ROICexc growth 3Y-4.41%
ROICexc growth 5Y18.23%
OM growth 3Y8.37%
OM growth 5Y21.34%
PM growth 3Y8.89%
PM growth 5Y31.03%
GM growth 3Y7.95%
GM growth 5Y11.43%
F-Score5
Asset Turnover1.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 150.26%
Cap/Sales 2.13%
Interest Coverage 250
Cash Conversion 78.99%
Profit Quality 93.52%
Current Ratio 5.06
Quick Ratio 3.89
Altman-Z N/A
F-Score5
WACC11.07%
ROIC/WACC1.78
Cap/Depr(3y)123.77%
Cap/Depr(5y)107.87%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.47%
Profit Quality(3y)100.14%
Profit Quality(5y)100.88%
High Growth Momentum
Growth
EPS 1Y (TTM)14.75%
EPS 3Y8.81%
EPS 5Y42.6%
EPS Q2Q%21%
EPS Next Y7.47%
EPS Next 2Y9.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.19%
Revenue growth 3Y0%
Revenue growth 5Y9.17%
Sales Q2Q%26.1%
Revenue Next Year11.13%
Revenue Next 2Y9.98%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.47%
EBIT growth 3Y8.36%
EBIT growth 5Y32.46%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.57%
FCF growth 3Y26.43%
FCF growth 5Y27.29%
OCF growth 1Y-3.99%
OCF growth 3Y27.49%
OCF growth 5Y26.36%